logo
#

Latest news with #LotharThielen

Dräger Atlan anesthesia workstations obtain Authority to Operate (ATO) under Risk Management Framework
Dräger Atlan anesthesia workstations obtain Authority to Operate (ATO) under Risk Management Framework

Yahoo

time11-08-2025

  • Business
  • Yahoo

Dräger Atlan anesthesia workstations obtain Authority to Operate (ATO) under Risk Management Framework

Certification ensures highest level of patient data security a medical device can attain Effective 7/14/2025 and expiring on 7/14/2028 under eMASS System ID #4060 TELFORD, Pa., Aug. 11, 2025 /PRNewswire/ -- Today Dräger, an international leader in medical and safety technologies, announced that the company's Atlan A350/A350 XL series of anesthesia workstations received Authority to Operate (ATO) certification under the Department of Defense's (DoD) Risk Management Framework (RMF) eMASS #4060. "Cyberattacks continue to be a serious threat to hospitals – both clinically and financially," said President and CEO for Draeger, Inc., Lothar Thielen. "To help hospitals meet this challenge, Dräger embeds the latest cybersecurity technology deeply into our development processes. Our new Atlan anesthesia workstations now carry ATO certification, which is the highest level of security a medical device can hold." Continuing a longstanding commitment to patient data securityCertification of Dräger's Atlan A350/A350XL anesthesia workstation follows the certifications of the Perseus A500 (eMASS # 2852) and Fabius MRI (eMASS # 2875) anesthesia workstations. Now with the Atlan certification, Dräger anesthesia customers can have confidence knowing that Dräger's entire anesthesia machine portfolio has gone through this rigorous cyber-security review process. Benefits of ATO-certified medical devicesMedical devices that have achieved an Authority to Operate (ATO) under the Risk Management Framework (RMF) offer significant advantages to hospitals, including: Enhanced security: Rigorous security assessments ensure that these devices meet high standards for protecting sensitive patient data and maintaining the integrity of medical operations Compliance assurance: Devices that comply with federal regulations and standards reduce the risk of legal and regulatory issues Reliability and trust: Hospitals can trust that these devices have been thoroughly vetted for security and performance, leading to greater confidence in their use in critical environments Interoperability: Devices with ATO are often designed to integrate seamlessly with other systems within the healthcare network, enhancing overall efficiency and effectiveness Continuous monitoring: Ongoing monitoring and updates continually address new security threats, ensuring that devices remain secure over time Faster installation: ATO-certified devices streamline the process of integrating device data with electronic medical records, centralized alarm stations, and remote notifications These benefits enable ATO-certified medical devices to provide stronger patient data protection and carry a lower risk of cyberattacks. More information:Dräger Atlan A350/A350 XL family of devices: You can find more information and pictures in our press center: Dräger. Technology for is a leading international medical and safety technology company. Our products protect, support and save lives. Founded in Lübeck, Germany in 1889, Dräger generated global sales of around EUR 3,4 billion in 2024. The Lübeck-based company is represented in more than 190 countries and employs more than 16,000 people worldwide. For more information, visit ContactCommunications: Melanie Kamann, Tel. +49 451 882-3202, Press Contact North America: Laura Edwards, Tel. +1 215 565-5868, Investor Relations: Thomas Fischler, Tel. +49 451 882-2685, View original content to download multimedia: SOURCE Draeger

Dräger Receives Frost & Sullivan's 2025 Global Company of the Year Recognition for Excellence in Respiratory Devices Innovation
Dräger Receives Frost & Sullivan's 2025 Global Company of the Year Recognition for Excellence in Respiratory Devices Innovation

Cision Canada

time10-07-2025

  • Business
  • Cision Canada

Dräger Receives Frost & Sullivan's 2025 Global Company of the Year Recognition for Excellence in Respiratory Devices Innovation

Dräger recognized for pioneering innovations in respiratory care, delivering measurable improvements in patient outcomes, clinical efficiency, cost-effectiveness and critical care training SAN ANTONIO, July 10, 2025 /CNW/ -- Frost & Sullivan is pleased to announce that Dräger has received the 2025 Global Company of the Year Award in the respiratory devices industry for its outstanding achievements in clinical innovation, cost-effective solutions, customer-centric strategy execution, and global market impact. This recognition underscores Dräger's continued leadership in transforming respiratory care through advanced technologies, comprehensive training programs, and a deep-rooted commitment to improving patient outcomes and caregiver wellness in intensive care environments. Frost & Sullivan evaluates companies through a rigorous benchmarking process across two core dimensions: visionary innovation and customer impact. Dräger excelled in both, demonstrating its ability to align its innovation roadmap with market demand while executing with precision, scalability, and clinical relevance. "Keeping the customer need in mind, Dräger's designs focus on a range of consumer needs, including scalability, flexibility, low infection rates, low readmission rates, reduced costs, high return on investment for healthcare providers, workplace safety, process improvement, human error reduction, enhanced patient and family experiences, patient comfort, and operational efficiencies," said Utkarsha Soundankar, Industry Analyst at Frost & Sullivan. Guided by a long-term growth strategy focused on digital innovation, clinical partnerships, and value-based care, Dräger has demonstrated its ability to lead in a rapidly evolving respiratory care landscape. The company's sustained investment in smart ventilator technology, workflow integration, and clinician training has enabled it to scale its solutions across diverse healthcare systems globally. Innovation remains at the heart of Dräger's approach. Its V-Series ventilators—featuring SmartCare/PS, integrated capnography, proportional pressure support, and high-flow oxygen therapy—are purpose-built to support the improvement of clinical outcomes, reduce the duration of mechanical ventilation, and support bundled payment models. Dräger's recent achievement in securing Authority to Operate (ATO) certification for its Evita V800/V600, Babylog VN800, and Savina 300 ventilators from the US Department of Defense marks a significant milestone in medical device security, interoperability, and deployment in mission-critical environments. "Given the recent wave of market consolidation of vendors in the ventilation market, today's decision makers are seeking more than just high-quality devices—they're looking for trusted partners who are deeply committed to supporting the respiratory care community," said Lothar Thielen, President and CEO of Draeger, Inc. "This award is a powerful affirmation of Dräger's unwavering commitment to our customers to deliver exceptional value through a combination of industry-leading products, cost-effective accessories and comprehensive service solutions that help hospitals provide the highest standard of care." In addition to product innovation, Dräger is redefining the respiratory care ecosystem through its full-service offerings, including responsive maintenance programs, biomedical training, and digital education platforms. In 2024, the company introduced Dräger Virtuo, an immersive virtual reality platform for ICU, OR, and NICU training, unveiled at the American Association for Respiratory Care (AARC) Congress. Alongside this launch, the revitalized Dräger Academy continues to expand its impact by delivering more than 84,500 hours of CRCE credits annually and offering micro-learning modules tailored for clinicians' evolving needs. This integrated education model is designed to build clinical confidence and ensure rapid onboarding and knowledge retention—imperative in high-stakes care environments. Frost & Sullivan commends Dräger for setting the benchmark in strategic execution and customer-focused innovation in the respiratory devices industry. The company's holistic approach—combining clinical-grade technology, secure deployment, and professional development—continues to support redefining the standard for excellence in respiratory care. Its ability to aid in improving clinical workflows, lowering total cost of care, and expanding access to next-generation training aims to ensure lasting impact across global healthcare ecosystems. Each year, Frost & Sullivan presents the Company of the Year Award to a company that demonstrates outstanding strategy development and implementation, resulting in measurable improvements in market share, customer satisfaction, and competitive positioning. It recognizes forward-thinking organizations that are reshaping their industries through innovation and growth excellence. Frost & Sullivan Best Practices recognitions honor companies in various regional and global markets for demonstrating outstanding achievement and superior performance in leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify best practices in the industry. About Frost & Sullivan For six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders, and governments navigate economic changes and identify disruptive technologies, megatrends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion. Contact: E: [email protected] Dräger. Technology for Life Dräger is a leading international medical and safety technology company. Our products protect, support and save lives. Founded in Lübeck, Germany in 1889, Dräger generated global sales of around EUR 3 billion in 2022. The Lübeck-based company is represented in more than 190 countries and employs more than 14,000 people worldwide. For more information, visit

Dräger announces US availability of next- generation Polaris® OR lights
Dräger announces US availability of next- generation Polaris® OR lights

Yahoo

time03-04-2025

  • Health
  • Yahoo

Dräger announces US availability of next- generation Polaris® OR lights

TELFORD, Pa., April 3, 2025 /PRNewswire/ -- Innovations in surgical light technology can help ORs advance surgical precision, simplify workflow, and increase patient safety Three models – Comfort, Pro and Pro+– support various budgetary and surgical requirements Upgrade options enable individual system customization and support future scalability New portfolio of Polaris lights will be displayed at AORN Global Surgical Conference & Expo, Boston, MA, April 6-8, 2025, Dräger booth #1527 Designed to meet lighting requirements of today's OR surgical staff"Our design goal for our new generation of Polaris lights was to create a system that consistently delivers high quality, virtually shadow-free illumination – while being intuitive and easy to use," said President and CEO for Draeger, Inc., Lothar Thielen. "These factors combine to support work efficiency and patient safety." Dräger's next generation of Polaris OR lights have an advanced LED optical system that helps create a homogeneous surgical field with smooth edges, as well as a high-color-rendering index for faithful tissue reproduction. OR staff can precisely adjust the wide light field diameter and brightness range. In addition, surgical staff can set the color temperature to better distinguish types of tissue in steps using the standard light head control panel, or with stepless level adjustments using the touch display controller option. The Polaris Pro+, the premium model of the line, also includes active 3D shadow management technology that uses sensors to detect when an object, such as a staff member's head, is blocking light within the illuminated surgical field. The system automatically compensates for the obstruction by controlling individual LEDs – thus helping to ensure uninterrupted light by maintaining brightness and keeping the surgical field virtually shadow-free. Features to protect patients and surgeons The Polaris Pro and Pro+ models offer the Light Guard feature, which Dräger developed to help reduce the risk of patient injury. When two OR lights are used in combination and illumination is overlapped within the surgical field, it is essential to prevent excessive irradiant temperature levels on the patient's skin – particularly at high brightness levels. When this occurs, there is a potential risk of surface burns and tissue desiccation. Activating Light Guard limits the total light energy irradiance on both the skin and surgical field to a safe value of ≤700 W/m2 when two light heads are used simultaneously. For protection of surgeons, Polaris Pro and Pro+ models provide the new Anti-Glare and Eye Relax functions to help make work easier by decreasing unwanted contrasts and blue components in the light, which can strain the surgeon's eyes and create fatigue over time. To keep staff engaged with operation status, or to record the procedure, Polaris offers an optional 4K MedView camera to capture and share high-resolution video recordings of the operation. Advances in ergonomics and hygiene supportThe new portfolio of Polaris OR lights was designed to be easier to maneuver. At only 40 pounds and 24 inches in diameter, the light heads are compact, relatively lightweight, and require little effort to position – while staying virtually drift free over time. To help reduce OR preparation time for the next surgery, the Preset Manager feature can store up to 30 pre-configured custom light settings for different users or procedure types. With the push of a single button, all light system levels can be recalled – including brightness, surgical diameter, color temperature, and other feature activation settings. The new Polaris line also offers multiple user control options in addition to the light head control. For example, touch display controllers can be installed on the light head gimble, be wall mounted (surface or flush), or installed elsewhere in the OR space such as mounted on an equipment boom. Touch display controllers are designed to be intuitive and facilitate ergonomic control of the light and 4K camera functions. To support a fast and effective cleaning process, Dräger Polaris lights have a sleek, contemporary design with smooth surfaces and rounded edges, and are unharmed by recommended cleaning materials. To simplify cleaning, the MedView camera is integrated directly into the light head under the transparent cover. All Dräger devices in the OR workplace are designed to use the same disinfectant – helping to further streamline the disinfection process for cleaning personnel. More information: The new portfolio of Dräger Polaris OR lights will be available in the US April 1, 2025. Learn more about the Dräger Polaris Comfort, Pro and Pro+ surgical lights. You can find more information and pictures in our press center: Dräger. Technology for is an international leader in the fields of medical and safety technology. Our products protect, support, and save lives. Founded in 1889, Dräger generated revenues of around € 3,4 billion in 2024. The Dräger Group is currently present in over 190 countries and has more than 16,000 employees worldwide. Please visit for more information. Contact Communications: Melanie Kamann, Tel. +49 451 882-3202, Press Contact North America: Laura Edwards, Tel. +1 215 565-5868, Investor Relations: Thomas Fischler, Tel. +49 451 882-2685, View original content to download multimedia: SOURCE Draeger Sign in to access your portfolio

Dräger Evita V800/V600, Babylog VN800 and Savina 300 obtain Authority to Operate (ATO) under Risk Management Framework
Dräger Evita V800/V600, Babylog VN800 and Savina 300 obtain Authority to Operate (ATO) under Risk Management Framework

Yahoo

time11-02-2025

  • Business
  • Yahoo

Dräger Evita V800/V600, Babylog VN800 and Savina 300 obtain Authority to Operate (ATO) under Risk Management Framework

New certifications follow Dräger's previous ATO certification for a critical care ventilator Dräger Evita V800/V600 and Babylog VN800 family of devices, effective 1/23/2025 and expiring on 1/21/2028 under eMASS System ID 3984 Dräger Savina 300 series, effective 1/23/2025 and expiring on 1/21/2028 under eMASS System ID 3957 TELFORD, Pa., Feb. 11, 2025 /PRNewswire/ -- Dräger, an international leader in medical and safety technologies, today announced that its Evita V800/V600 and Babylog VN800 family of mechanical ventilators received Authority to Operate (ATO) certification under the Department of Defense's (DoD) Risk Management Framework (RMF) eMASS #3984. In addition, the Savina 300 series of mechanical ventilators received ATO certification under the DoD's RMF eMASS #3957. "At Dräger, our mission extends beyond clinical technology," said President and CEO for Draeger, Inc., Lothar Thielen. "In our quest to improve patient outcomes and health equity, we are also committed to protecting patient data. That's why we invest significant resources in cybersecurity, which has culminated in ATO certification – the highest level of security a device can hold." Dräger was one of the first companies to obtain an ATO for a critical care ventilatorCertification of Dräger's latest-technology ventilators follows that of the Dräger V500 series of ventilators, which achieved this level of security in 2020 under eMASS System ID 2510 and extends to 3/3/2026. With this ATO certification of a critical care ventilator – as well as many ATOs for other medical devices before 2020 – Dräger broke new ground in patient data security. Benefits of ATO-certified ventilatorsMedical devices that have achieved an Authority to Operate (ATO) under the Risk Management Framework (RMF) offer significant advantages to hospitals, including: Enhanced security: Rigorous security assessments ensure that these devices meet high standards for protecting sensitive patient data and maintaining the integrity of medical operations Compliance assurance: Devices that comply with federal regulations and standards reduce the risk of legal and regulatory issues Reliability and trust: Hospitals can trust that these devices have been thoroughly vetted for security and performance, leading to greater confidence in their use in critical environments Interoperability: Devices with ATO are often designed to integrate seamlessly with other systems within the healthcare network, enhancing overall efficiency and effectiveness Continuous monitoring: Ongoing monitoring and updates continually address new security threats, ensuring that devices remain secure over time Faster installation: ATO-certified devices streamline the process of integrating ventilator data with electronic medical records, centralized alarm stations, and remote notifications In short, ventilators that offer this level of security have stronger patient data protection and carry a lower risk of cyberattacks. More information:Dräger Evita V800/V600 family of devices [link]Dräger Babylog VN800 ventilator [link]Dräger Savina 300 series of ventilators [link] Dräger Evita V800The Evita V800 combines high performance ventilation with an ergonomic design, enabling intuitive and efficient operation. This integrated, patient-centered ventilation workplace enables caregivers to care for patients with various acuity levels – efficiently and cost effectively. D-3636-2019 Dräger Babylog VN800Designed specifically for fragile neonates, the Babylog VN800 has an intuitive user interface that helps make it safe and easy to operate. The system supports lung and brain protective ventilation modes throughout the baby's whole respiratory cycle, supporting a seamless transition from O2 therapy to non-invasive ventilation to invasive ventilation. D-12091-2019 Dräger Savina 300The Savina 300 is designed to be as non-invasive as possible, yet as invasive as necessary. The ventilator has automatic leak compensation to effectively support non-invasive ventilation. The built-in turbine has a rapid response time and an external battery enables it to be operated independently from the central gas supply. D-14953-2019 You can find more information and pictures in our press center: Dräger. Technology for is a leading international medical and safety technology company. Our products protect, support and save lives. Founded in Lübeck, Germany in 1889, Dräger generated global sales of around EUR 3 billion in 2022. The Lübeck-based company is represented in more than 190 countries and employs more than 14,000 people worldwide. For more information, visit ContactCommunications: Melanie Kamann, Tel. +49 451 882-3202, Contact North America: Laura Edwards, Tel. +1 215 565-5868, Relations: Thomas Fischler, Tel. +49 451 882-2685, View original content to download multimedia: SOURCE Draeger Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store